Edition:
United Kingdom

Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

6,020JPY
24 Nov 2017
Change (% chg)

¥-50 (-0.82%)
Prev Close
¥6,070
Open
¥6,010
Day's High
¥6,030
Day's Low
¥5,940
Volume
177,000
Avg. Vol
135,437
52-wk High
¥6,590
52-wk Low
¥4,985

Latest Key Developments (Source: Significant Developments)

Noven files patent infringement lawsuit against Alvogen
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - ‍Noven Pharmaceuticals :‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement.Says Alvogen is seeking approval to market & sell generic version of Minivelle prior to expiration of 2 of Noven's orange book listed patents​.  Full Article

Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Nikkei::Hisamitsu pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen ($111 million) in the March-August period‍​ - Nikkei.Sales of Hisamitsu Pharmaceutical probably fell 1% to about 74 billion yen in the March-August period - Nikkei.Hisamitsu Pharmaceutical Co Inc expected to maintain its guidance for the fiscal year ending February 2018 - Nikkei.  Full Article

Hisamitsu Pharmaceutical unit assigns rights for Brisdelle Capsules and Pexeva Tablets
Tuesday, 26 Jul 2016 

Hisamitsu Pharmaceutical Co Inc <4530.T>:Says its U.S.-based unit, Noven Pharmaceuticals, Inc., has reached agreement to assign rights of approval for manufacture, commercialization and associated intellectual property for Brisdelle(Paroxetine) Capsules, 7.5 mg and Pexeva(Paroxetine Mesylate) Tablets to Sebela International Limited.  Full Article

Hisamitsu Pharmaceutical says private placement of 1 mln treasury stocks
Friday, 8 Jul 2016 

Hisamitsu Pharmaceutical <4530.T>: Says it will distribute 1 million shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd. on Aug. 19 .Says it will raise 1 million yen in total through private placement.  Full Article

Hisamitsu Pharmaceutical sees sales down 4 pct to JPY 155 bln for FY 2017 - Nikkei
Monday, 27 Jun 2016 

Nikkei: Hisamitsu Pharmaceutical's operating profit apparently took a 13 pct hit for the march-May Quarter - Nikkei . Hisamitsu Pharmaceutical forecasts sales falling 4 pct to 155 billion yen for the year ending February 2017 - NIKKEI .Hisamitsu Pharmaceutical likely earned around 5 bln yen ($49.2 mln) in profit for march-may quarter on a group basis - Nikkei.  Full Article

HISAMITSU PHARMACEUTICAL to issue year-end dividend for FY 2016
Friday, 8 Apr 2016 

HISAMITSU PHARMACEUTICAL CO INC:To issue a year-end dividend of 41 yen per share to all the shareholders of record as of Feb. 29, for FY ended Feb. 2016.Payment date May 27.Says latest dividend forecast was 40 yen per share.  Full Article

HISAMITSU PHARMACEUTICAL announces private placement of treasury stock; to repurchase shares
Friday, 8 Apr 2016 

HISAMITSU PHARMACEUTICAL CO INC:To distribute 1,000,000 shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd.To raise 1 million yen in total through private placement.Says it will repurchase up to 2,000,000 shares of its common stock, representing a 2.36 pct stake by Dec. 31.Share repurchase price is 12,000,000,000 yen in total.  Full Article

BRIEF-Noven files patent infringement lawsuit against Alvogen

* ‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement